The draft FDA guidelines on patient-reported outcomes in cancer trials change the way we design and implement COA measurement strategies in oncology trials.
In episode three of our "Clinical Viewpoints" video series, Todd Everhart, MD, our Clinical VP of Internal Medicine, provides insights for good measurement strategy in oncology designs and how to leverage decentralized methods to optimize the trial participation experience for patients and sites.
